Identification of the α2 chain of interleukin‐13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient‐derived xenograft models

Identification of the α2 chain of interleukin‐13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient‐derived xenograft models

Abstract Background Several treatment strategies use upfront chemotherapy or androgen receptor axis‐targeting therapies for metastatic prostate cancer. However, there are no useful biomarkers for selecting appropriate patients who urgently require these treatments. Methods Novel patient‐derived xeno...

Full description

Bibliographic Details
Main Authors: Takahiro Nagai, Naoki Terada, Masato Fujii, Yasuhisa Nagata, Kozue Nakahara, Shoichiro Mukai, Kosuke Okasho, Yuki Kamiyama, Shusuke Akamatsu, Takashi Kobayashi, Kei Iida, Masatsugu Denawa, Masatoshi Hagiwara, Takahiro Inoue, Osamu Ogawa, Toshiyuki Kamoto
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Reports
Subjects:
biomarker
castration resistance
Interleukin‐13 receptor α2
patient‐derived xenograft
prostate cancer
Online Access:https://doi.org/10.1002/cnr2.1701

Internet

https://doi.org/10.1002/cnr2.1701

Similar Items